1. Home
  2. GENC vs MIST Comparison

GENC vs MIST Comparison

Compare GENC & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$14.82

Market Cap

210.0M

Sector

Industrials

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.22

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
MIST
Founded
N/A
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.0M
176.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
GENC
MIST
Price
$14.82
$1.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$17.60
$8.00
AVG Volume (30 Days)
28.0K
1.5M
Earning Date
02-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
8.08
N/A
EPS
0.23
N/A
Revenue
$48,943,000.00
N/A
Revenue This Year
N/A
$2,915.14
Revenue Next Year
$25.51
N/A
P/E Ratio
$63.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$1.00
52 Week High
$17.40
$3.06

Technical Indicators

Market Signals
Indicator
GENC
MIST
Relative Strength Index (RSI) 50.40 26.80
Support Level $14.57 $1.00
Resistance Level $15.66 $2.30
Average True Range (ATR) 0.46 0.08
MACD 0.05 -0.02
Stochastic Oscillator 54.47 4.40

Price Performance

Historical Comparison
GENC
MIST

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: